{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:43:27Z","timestamp":1774543407039,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The efficacy of finafloxacin as a component of a layered defense treatment regimen was determined <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> against an infection with <jats:italic>Burkholderia pseudomallei<\/jats:italic>. Doxycycline was down-selected from a panel of antibiotics evaluated <jats:italic>in vitro<\/jats:italic> and used in combination with finafloxacin in a Balb\/c mouse model of inhalational melioidosis. When treatment was initiated at 24 h post-infection with <jats:italic>B. pseudomallei<\/jats:italic>, there were no differences in the level of protection offered by finafloxacin or doxycycline (as monotherapies) when compared to the combination therapy. There was evidence for improved bacterial control in the groups treated with finafloxacin (as monotherapies or in combination with doxycycline) when compared to mice treated with doxycycline. Survival comparisons of finafloxacin and doxycycline (as monotherapies) or in combination initiated at 36 h post-infection indicated that finafloxacin was superior to doxycycline. Doxycycline was also unable to control the levels of bacteria within tissues to the extent that doxycycline and finafloxacin used in combination or finafloxacin (as a sole therapy) could. In summary, finafloxacin is a promising therapy for use in the event of exposure to <jats:italic>B. pseudomallei.<\/jats:italic><\/jats:p>","DOI":"10.3389\/fmicb.2022.934312","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T07:32:40Z","timestamp":1660635160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation of a combination therapy approach for the treatment of melioidosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Kay B.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark I.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Maishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah V.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.","volume":"58","author":"Agwuh","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1128\/AAC.43.5.1298","article-title":"In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.","volume":"43","author":"Akova","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1128\/AAC.01231-08","article-title":"\u03b2-Lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative Bacilli.","volume":"53","author":"Al-Hasan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/AAC.00082-17","article-title":"Demonstrating the protective efficacy of the novel fluoroquinolone finafloxacin against an inhalational exposure to Burkholderia pseudomallei.","volume":"61","author":"Barnes","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1128\/AAC.01470-19","article-title":"Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest.","volume":"63","author":"Barnes","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fmicb.2019.00904","article-title":"The fluoroquinolone finafloxacin protects BALB\/c mice against an intranasal infection with Francisella tularensis strain SchuS4.","volume":"10","author":"Barnes","year":"","journal-title":"Front. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e02294-20","DOI":"10.1128\/AAC.02294-20","article-title":"Finafloxacin is an effective treatment for inhalational tularemia and plague in mouse models of infection.","volume":"65","author":"Barnes","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.07.028","article-title":"Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmacokinetics in THP-1 monocytes.","author":"Chalhoub","year":"2019","journal-title":"Clin. Microbiol.Inf."},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1099-1557(199703)6:2<89::AID-PDS261>3.0.CO;2-8","article-title":"Co-trimoxazole-induced severe haemolysis: the experience of a large general hospital in Hong Kong.","volume":"6","author":"Chan","year":"1997","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2008.78.208","article-title":"Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.","volume":"78","author":"Cheng","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1201\/b18041","author":"Collett","year":"2015","journal-title":"Modelling Survival Data in Medical Research."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"B13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis.","volume":"43","author":"Dance","year":"2014","journal-title":"Intl. J. Antimicrob. Agents"},{"key":"B14","first-page":"281","article-title":"Lactic acidosis.","volume":"69","author":"De Backer","year":"2003","journal-title":"Minerva Anestesiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3201\/eid2608.191806","article-title":"Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium.","volume":"26","author":"Durukan","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B16","article-title":"Time kill assay for determining synergy","author":"Garcia","year":"2007","journal-title":"Clinical Microbiology Procedures Handbook"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/srep01146","article-title":"Efficacy of post exposure administration of doxycycline in a murine model of inhalational melioidosis.","volume":"3","author":"Gelhaus","year":"2013","journal-title":"Sci. Rep."},{"key":"B18","article-title":"Investigation of In vitro antagonistic and synergistic effects of finafloxacin in combination with other antibiotics","author":"Goh","year":"2011","journal-title":"Poster Presented at the 51st ICACC"},{"key":"B19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals.","volume":"150","author":"Guyton","year":"1947","journal-title":"The Am. J. Physiol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0022172400039504","article-title":"A method for measuring the retained dose in experiments on airborne infection.","volume":"60","author":"Harper","year":"1962","journal-title":"J. Hyg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"760698","DOI":"10.3389\/fmicb.2021.760698","article-title":"Finafloxacin, a novel fluoroquinolone, reduces the clinical signs of infection and pathology in a mouse model of Q fever.","volume":"12","author":"Hartley","year":"2021","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1613-1615","DOI":"10.1128\/AAC.01637-09","article-title":"Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin sensitive and resistant Acinetobacter baumannii isolates.","volume":"54","author":"Higgins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim-sulfamethoxazole.","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"132971","DOI":"10.1155\/2014\/132971","article-title":"Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.","volume":"2014","author":"Khosravi","year":"2014","journal-title":"Sci. World J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijantimicag.2011.03.002","article-title":"Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.","volume":"38","author":"Lemaire","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/507632","article-title":"Risk factors for recurrent melioidosis in northeast Thailand.","volume":"43","author":"Limmathurotsakul","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B27","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis.","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"103152","DOI":"10.1016\/j.ebiom.2020.103152","article-title":"Taking the next gen step: Comprehensive antimicrobial resistance detection from Burkholderia pseudomallei.","volume":"63","author":"Madden","year":"2021","journal-title":"Ebio Medi."},{"key":"B29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00408-004-2511-6","article-title":"Innate host defense of the lung: effects of lung-lining fluid pH.","volume":"182","author":"Ng","year":"2004","journal-title":"Lung"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1473","DOI":"10.1371\/journal.pntd.0001473","article-title":"Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.","volume":"6","author":"O\u2019Brien","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Abel zur Wiesch P, Busa-Fekete R, Fekete G, P\u00e1l C, Ackermann M, Bonhoeffer S. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent.","volume":"58","author":"Ocampo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1128\/AAC.00832-10","article-title":"Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers.","volume":"55","author":"Patel","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0106121","DOI":"10.1128\/AAC.01061-21","article-title":"Intracellular activity of antibiotics against Coxiella burnetii in a model of activated human THP-1 cells.","volume":"65","author":"Peyrusson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1600-0714.1987.tb00674.x","article-title":"Evaluation of pH changes in inflammation of the subcutaneous air pouch lining in the rat, induced by carrageenan, dextran and Staphylococcus aureus.","volume":"16","author":"Punnia-Moorthy","year":"1987","journal-title":"J. Oral Pathol."},{"key":"B35","first-page":"e14461","article-title":"Molecular epidemiology and antibiotic resistance of Burkholderia pseudomallei isolates from Hainan.","volume":"98","author":"Rao","year":"2019","journal-title":"China Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fcimb.2018.00210","article-title":"Evaluating new compounds to treat Burkholderia pseudomallei infections.","volume":"8","author":"Ross","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0008913","DOI":"10.1371\/journal.pntd.0008913","article-title":"Genomic and RT-qPCR analysis of trimethoprim-sulfamethoxazole and meropenem resistance in Burkholderia pseudomallei clinical isolates.","volume":"15","author":"Schnetterle","year":"2021","journal-title":"PLoS Neg. Trop. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1128\/AAC.32.9.1450","article-title":"In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.","volume":"32","author":"Smith","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1128\/AAC.00833-10","article-title":"In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.","volume":"55","author":"Stubbings","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1016\/j.ijid.2008.05.305","article-title":"The effect of using combinations of commonly used antibiotics in Sudan on resistant gram negative bacterial isolates.","volume":"12","author":"Sulieman","year":"2008","journal-title":"Intl. J. Infect. Dis."},{"key":"B41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijid.2019.01.019","article-title":"Oral eradication therapy for melioidosis; important but not without risks.","volume":"80","author":"Sullivan","year":"2019","journal-title":"Intl. J. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0008659","DOI":"10.1371\/journal.pntd.0008659","article-title":"Review and revision of the 2015 darwin melioidosis treatment guideline; paradigm drift not shift.","volume":"14","author":"Sullivan","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/jac\/dkm527","article-title":"Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin\/clavulanic acid and co-trimoxazole.","volume":"61","author":"Sivalingam","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1038\/s41598-019-54556-6","article-title":"The effect of ph on antibiotic efficacy against Coxiella burnetii in axenic media.","volume":"9","author":"Smith","year":"2019","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.","volume":"54","author":"Thibault","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fcimb.2012.00101","article-title":"Particle-size dependent effects in the Balb\/c murine model of inhalational melioidosis.","volume":"2","author":"Thomas","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e2325","DOI":"10.1128\/AAC.02325-17","article-title":"Early clinical assessment of the antimicrobial activity of finafloxacin compared to ciprofloxacin in subsets of microbiologically characterized isolates.","volume":"62","author":"Vente","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2317","DOI":"10.1128\/AAC.02317-17","article-title":"Explorative randomized phase II clinical study of the efficacy and safety of finafloxacin versus ciprofloxacin for treatment of complicated urinary tract infections.","volume":"62","author":"Wagenlehner","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1128\/JCM.37.6.1881-1884.1999","article-title":"Methods for determining bactericidal activity of antimicrobial agents: approved guideline M-26-A.","volume":"19","author":"Wayne","year":"1999","journal-title":"Clin. Lab. Stand. Inst."},{"key":"B50","doi-asserted-by":"crossref","first-page":".e1","DOI":"10.1016\/j.urology.2014.04.048","article-title":"The influence of urinary pH on antibiotic efficacy against bacterial uropathogens.","volume":"84","author":"Yang","year":"2014","journal-title":"Urology"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.934312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T07:33:00Z","timestamp":1660635180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.934312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":50,"alternative-id":["10.3389\/fmicb.2022.934312"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.934312","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"934312"}}